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The basal ganglia play a critical role in shaping
motor behavior. For this function, the activity of me-
dium spiny neurons (MSNs) of the striatonigral and
striatopallidal pathways must be integrated. It re-
mains unclear whether the activity of the two path-
ways is primarily coordinated by synaptic plasticity
mechanisms. Using a model of Parkinson’s disease,
we determined the circuit and behavioral effects of
concurrently regulating cell-type-specific forms of
corticostriatal long-term synaptic depression (LTD)
by inhibiting small-conductance Ca2+-activated K+
channels (SKs) of the dorsolateral striatum.At striato-
pallidal synapses, SK channel inhibition rescued the
disease-linked deficits in endocannabinoid (eCB)-
dependent LTD. At striatonigral cells, inhibition of
these channels counteracted a form of adenosine-
mediated LTD by activating the ERK cascade.
Interfering with eCB-, adenosine-, and ERK signaling
in vivo alleviated motor abnormalities, which sup-
ports that synaptic modulation of striatal pathways
affects behavior. Thus, our results establish a central
role of coordinated synaptic plasticity at MSN sub-
populations in motor control.INTRODUCTION
The dorsal striatum nucleus (DS) of the basal ganglia plays a cen-
tral role in the physiological control of action selection and motor
function (Packard and Knowlton, 2002). Motor information orig-
inating from cortical inputs converges on the medium spiny neu-
rons (MSNs) of the DS. TheseMSNs express either D1 dopamine
receptor (D1R) or D2 dopamine receptor (D2R), constituting theCell Repstriatonigral (D1MSN) and striatopallidal (D2MSN) projection path-
ways, respectively (Albin et al., 1989; Kreitzer, 2009).
Dopamine released by projections from the substantia nigra
pars compacta oppositely affects synaptic transmission in
D1MSN and D2MSN, depending onwhich receptor subtype is acti-
vated. In D1MSN, dopamine strengthens cortical synaptic con-
nections through the positive regulation of NMDA receptors
and activation of the extracellular-signal regulated kinase (ERK)
pathway (Cerovic et al., 2013; Girault et al., 2007). These cellular
events ultimately trigger synaptic long-term potentiation (LTP) of
glutamatergic cortical afferents (Calabresi et al., 1992; Cerovic
et al., 2015; Pascoli et al., 2012).
In contrast, in D2MSN, dopamine contributes to the depression
of cortical inputs by gating the biosynthesis and release of local
lipid mediator endocannabinoids (eCBs) (Lerner and Kreitzer,
2012). The synthesis of eCBs is dependent on the activation of
metabotropic receptors (e.g., D2R and mGluRs1/5) and eleva-
tion of cytosolic Ca2+ concentration (Lerner and Kreitzer, 2012;
Uchigashima et al., 2007). The eCBs act as retrograde messen-
gers by activating the presynaptic CB1 cannabinoid receptor
(CB1R), which decreases the probability of glutamate release
and leads to long-term synaptic depression (eCB-LTD) (Gerde-
man et al., 2002; Kreitzer and Malenka, 2007; Nazzaro et al.,
2012; Shen et al., 2008; Wang et al., 2006).
Dopamine and eCB-mediated control of excitatory synaptic
inputs to the DS is disrupted in animal models of motor disor-
ders, including Parkinson’s disease (PD) (Tritsch and Sabatini,
2012). In fact, some of the synaptic alterations found in PD
mouse models involve deficits in dopamine-dependent LTP
and eCB-LTD at striatal excitatory synapses (Kreitzer and Mal-
enka, 2007; Picconi et al., 2003; Shen et al., 2008). These synap-
tic dysfunctions could potentially contribute to the striatonigral
hypoactivity and striatopallidal hyperactivity characterizing the
pathology, and ultimately to its motor symptoms (Albin et al.,
1989; Kreitzer and Malenka, 2007).
For appropriate motor control, the dynamic integration be-
tween D1MSN and D2MSN activity appears to be crucial (Cuiorts 13, 1353–1365, November 17, 2015 ª2015 The Authors 1353
Figure 1. HFS-Induced LTD at Corticostriatal Afferents to D2MSN and
D1MSN
(A) (Left) Microphotograph of a horizontal slice displays the stimulation (Stim)
and recording configuration (Rec) in the DLS. Ctx, cortex; cc, corpus cal-
losum; scale bar, 300 mm. (Right) Postsynaptic response (black trace, top) to
1354 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The Auet al., 2013; Tecuapetla et al., 2014), and loss of dopaminergic
neurotransmission might cause abnormal coordination between
the two projection pathways (Calabresi et al., 2014). However,
the precise cellularmechanisms shaping the coordinated activity
of D1MSN and D2MSN have yet to be established. We hypothesize
that the two pathways may be coordinated through concurrent,
cell-type-specific regulation of corticostriatal synaptic plasticity
at D1MSN and D2MSN. The loss of this regulation could disrupt
motor control, leading to PD motor deficits.
To begin to address these hypotheses, we sought to identify
the key presynaptic mechanisms that cooperate with postsyn-
aptic dopaminergic signaling to regulate cell-type-specific forms
of LTD at cortical connections to D1MSN and D2MSN. We then
investigated whether this functional interplay of presynaptic
and postsynaptic molecular determinants of synaptic plasticity
is lost in amousemodel of PD (the unilateral 6-hydroxydopamine
[6-OHDA]-lesioned mouse).
We further examined whether it is possible to rescue PDmotor
deficits by mimicking the effect of postsynaptic dopaminergic
regulation of plasticity by activating Ca2+-dependent intracel-
lular signaling cascades that act downstream of D2 and D1
dopamine receptors. In PD mice, bypassing dopamine signaling
rescues disease-linked deficits in eCB-LTD in D2MSN, and it
counteracts a form of adenosine-mediated LTD in D1MSN by
activating the postsynaptic ERK cascade. Activating eCB and
ERK signaling in vivo alleviates specific motor abnormalities,
improving motor control. These results establish that coordi-
nated regulation of synaptic plasticity at striatal MSN subpopu-
lations plays a major role in the control of motor function and in
motor pathology.
RESULTS
Corticostriatal LTD in D2MSN and D1MSN Is Regulated by
Different Mechanisms
To study synaptic plasticity at cortical connections to D2MSN and
D1MSN of the dorsolateral striatum (DLS), we recorded evoked
excitatory postsynaptic potentials (EPSPs) in physiological K+-
based intracellular conditions (high K+), upon stimulation of the
deep cortical layer V of the somatosensory cortex (Figure 1).
D2MSN and D1MSN were identified by their negative resting mem-
brane potentials (D2MSN, 81 ± 0.4 mV, n = 62; D1MSN, 80 ±
0.3 mV, n = 69), firing activity (Figure S1A; Kreitzer and Malenka,the HFS-pairing protocol for the induction of LTD (red trace, bottom) is
shown.
(B and C) (Left) Time courses of normalized EPSP amplitude and normalized
Rinp (mean ± SEM). (Insets) Averaged recordings (ten traces) before (black line)
and after (red line) the delivery of the HFS protocol are shown. HFS stimulation
is indicated by the red vertical bar. (Middle) Bar diagrams summarize the ratios
of post-HFS and pre-HFS synaptic responses. (Right) Comparison of CV2
before and after HFS delivery is shown (D2MSN, p = 0.03; D2MSN + AM251, p =
0.9; D1MSN, p = 0.04; D1MSN + AM251, p = 0.02; paired t test:). CV
2 calcu-
lations were based on 60 sweeps at 10 min before and 20 min after HFS. (B)
LTD at cortical connections to D2MSN was abolished by the CB1R antagonist
AM251 (4 mM; RM2W, F1,11 = 17, p = 0.0014; D2MSN versus D2MSN + AM251,
p < 0.01, Bonferroni). (C) LTD at cortical connections to D1MSN was insensitive
to CB1R antagonism (RM2W, F1,15 = 0.1, p = 0.76; D1MSN versus D1MSN +
AM251).
thors
2007), and after recording by immunostaining for adenosine A2A
receptor (A2AR, for D2MSN) and substance P (SP, for D1MSN)
(Figure S1B).
At cortical connections to D2MSN, high-frequency stimulation
(HFS) (Figure 1A) resulted in LTD of postsynaptic responses
(49% ± 7% of baseline, n = 7; p < 0.05; Figure 1B). This plasticity
is dependent on eCB signaling, as it was blocked by the CB1R
antagonist AM251 (4 mM) (93% ± 9% of baseline, n = 6; p >
0.05; Figure 1B). In D1MSN, the same HFS protocol also triggered
a long-term depression (HFS-LTD) of EPSPs (60% ± 9%of base-
line, n = 7; p < 0.05; Figure 1C). However, in D1MSN, the HFS-LTD
was unchanged by inhibiting CB1R (57% ± 7% of baseline,
n = 10; p < 0.05; Figure 1C).
The plasticity in both D2MSN and D1MSN was associated with
changes in the coefficient of variation (CV) of individual evoked
EPSP after HFS, as reflected by the decreased CV2 (CV2 for
D2MSN, before: 20 ± 2, after: 13 ± 3, n = 6, p < 0.05; CV
2 for
D1MSN, before: 22 ± 5, after: 14 ± 4, n = 5, p < 0.05; Figures 1B
and 1C). This result suggests a presynaptic locus of plasticity
(Fino et al., 2005) in both populations. HFS-induced changes
of CV2 were abolished by AM251 selectively in D2MSN, (CV
2
for D2MSN, before: 20 ± 4, after: 20 ± 5, n = 6, p > 0.05; CV
2
for D1MSN, before: 32 ± 5, after: 17 ± 5, n = 8, p < 0.05), support-
ing that activation of presynaptic CB1R mediates LTD at cortical
connections to D2MSN (Kreitzer and Malenka, 2007; Nazzaro
et al., 2012). To confirm this, we interfered with postsynaptic
production of eCBs by targeting the enzymes phospholipase
C-b (PLCb) and phospholipase D (PLD), which participate in
eCB biosynthesis in MSNs following HFS (Lerner and Kreitzer,
2012). The combined intracellular application of the PLCb inhib-
itor U73122 (1 mM) and the PLD inhibitor CAY10594 (100 mM) fully
prevented eCB-LTD in D2MSN (94% ± 9% of baseline, n = 5; p >
0.05; Figure 2A), but not in D1MSN (54% ± 11% of baseline, n = 6;
p < 0.05; Figure 2D). Consistent with previous observations
(Lerner and Kreitzer, 2012), inhibiting PLD alone was sufficient
to impair plasticity at D2MSN synapses (D2MSN, 95% ± 9% of
baseline, n = 7; p > 0.05; Figure 2A). The same manipulation
had no effect on D1MSN (D1MSN, 52% ± 11% of baseline, n = 5;
p < 0.05; Figure 2D). Taken together, these results demonstrate
that eCB-mediated plasticity shows a bias toward cortico-
D2MSN afferents.
The enzymatic activities of PLCb and PLD and the biosyn-
thesis of eCBs are stimulated by elevation of intracellular Ca2+
(Gerdeman et al., 2002; Lerner and Kreitzer, 2012). Including
the calcium chelator BABTA (20mM) in the postsynaptic neurons
prevented LTD at D2MSN synapses (97% ± 8% of baseline, n = 6;
p > 0.05; Figure 2B), but not in D1MSN (48% ± 11% of baseline,
n = 5; p < 0.05; Figure 2E). This is further evidence that cortically
induced LTD is driven by different mechanisms in D2MSN and
D1MSN.
Our data indicating that eCBs do not gate HFS-induced LTD at
D1MSN synapses agree with some previous studies (Kreitzer and
Malenka, 2007; Nazzaro et al., 2012), but contradict others (Ba-
getta et al., 2011;Wang et al., 2006).We therefore askedwhether
D1MSN could express a form of eCB-dependent LTD when the
postsynaptic biosynthesis of eCBs is facilitated, such as upon
stimulation of mGlurR1/5 (Uchigashima et al., 2007). To test
this, we measured changes in the amplitude of EPSPs at corticalCell Repsynapses in D2MSN andD1MSN after application of themGlurR1/5
agonist DHPG (100 mM; postsynaptic neuron held at 60 mV;
Figure S2). We found that DHPG triggered a form of synaptic
depression (D2MSN, 61% ± 8% of baseline, n = 8; p < 0.05;
D1MSN, 71%± 6%of baseline, n = 10; p < 0.05) that was sensitive
to the CB1R antagonist AM251 (4 mM) in both neuronal subpop-
ulations (D2MSN, 91% ± 6% of baseline, n = 6; p > 0.05; D1MSN,
91% ± 2% of baseline, n = 7; p > 0.05; Figures S2A and S2B).
Overall, these results indicate that HFS-LTD at cortical affer-
ents to D1MSN is not primarily gated by eCBs, which can, how-
ever, be released to depress cortical inputs in response to the
direct pharmacological activation of mGlur1/5R.
Dopamine SignalingModulates LTDOppositely in D2MSN
and D1MSN
We next investigated how dopamine signaling modulates LTD in
the two MSN subpopulations. Previous studies have indicated
that LTD obtained by stimulation of excitatory afferents to the
striatum requires the activation of D2R in both D2MSN and
D1MSN (Bagetta et al., 2011; Wang et al., 2006). To test whether
this was the case in our experimental setting, we treated slices
with the D2R antagonist sulpiride (10 mM). Under these condi-
tions, LTD was impaired at cortical connections to D2MSN
(85% ± 5% of baseline, n = 6; p > 0.05; Figure 2C), consistent
with the contribution of D2 signaling to eCB biosynthesis upon
HFS (Lerner and Kreitzer, 2012). Conversely, HFS-LTD at cortical
afferents on D1MSN was not affected by inhibiting D2R (D1MSN,
50% ± 5% of baseline, n = 8; p < 0.05; Figure 2F).
In D1MSN, postsynaptic D1R activation positively regulates the
NMDA receptor and ERK signaling cascade, thus increasing
synaptic responsiveness to cortical inputs (Cahill et al., 2014;
Cerovic et al., 2013; Girault et al., 2007). It is, therefore, possible
that D1R activation hinders HFS-LTD in D1MSN. This is indeed the
case, as the D1R agonist SKF38393 (3 mM) markedly reduced
LTD at cortical connections to D1MSN (88% ± 6% of baseline,
n = 6; p > 0.05; Figure 2F).
Collectively, our data indicate that postsynaptic dopaminergic
signaling downstream of D2R in D2MSN and D1R in D1MSN oppo-
sitely regulates LTD.
Adenosine Mediates HFS-LTD in D1MSN
To elucidate the mechanisms underlying the induction of LTD by
HFS in D1MSN, we tested the involvement of distinct classes of
presynaptic receptors that could regulate the release of gluta-
mate at corticostriatal afferents. In other brain regions, the acti-
vation of presynaptic NMDA receptors (NMDARs) can trigger a
long-lasting depression of glutamatergic neurotransmission
(Min and Nevian, 2012). This was not the case in the DS, as
HFS-LTD in D1MSN was unaffected by the NMDAR antagonist
DL-APV (50 mM; 56% ± 12% of baseline, n = 5; p < 0.05; Fig-
ure 3A). The presynaptic group 2-metabotropic glutamate
receptors (mGluR2/3) have been shown to induce pharmacolog-
ical LTD at excitatory striatal synapses (Kupferschmidt and
Lovinger, 2015). However, the selective mGlur2/3 antagonist
LY341495 (200 nM) did not prevent LTD upon HFS in D1MSN
(58% ± 5% of baseline, n = 5; p < 0.05; Figure 3B).
A1 adenosine receptors (A1Rs) have been identified at striatal
glutamatergic terminals, where they can negatively modulateorts 13, 1353–1365, November 17, 2015 ª2015 The Authors 1355
Figure 2. Modulation of HFS-LTD at
Cortical Connections to D2MSN and D1MSN
(A and D) The combined intracellular application of
the PLCb inhibitor U73122 (1 mM) and PLD inhibitor
CAY10594 (100 mM) prevented LTD induction in
D2MSN (A), but not in D1MSN (D). Similar results
were obtained when CAY10594 was applied in
isolation (A; RM2W, F2,16 = 12, p = 0.0007;
D2MSN + U73122/CAY10594 versus D2MSN, p <
0.01; D2MSN + CAY10594 versus D2MSN, p <
0.001, Bonferroni; D; 2WRM, F2,15 = 0.15, p = 0.9).
(B and E) Intracellular application of the Ca2+
chelator BABTA (20 mM) inhibited LTD in D2MSN
(B; RM2W, F1,11 = 39.2, p < 0.001; D2MSN BABTA
versus D2MSN, p < 0.001, Bonferroni), but not in
D1MSN (E; RM2W, F1,10 = 0.69, p = 0.43; D1MSN
BABTA versus D1MSN).
(C and F) eCB-LTD and HFS-LTD showed differ-
ences in sensitivity to bath application of the D2
receptor antagonist sulpiride (10 mM; C; D2MSN,
gray bar; F; D1MSN, black bar). Compared to
control conditions (Figures 1B and 1C), sulpiride
reduced eCB-LTD at cortical connections to
D2MSN (C; RM2W, F1,11 = 20, p = 0.001; D2MSN +
sulpiride versus D2MSN, p < 0.01, Bonferroni), but
failed to inhibit HFS-LTD at cortical afferents on
D1MSN (F; RM2W, F1,13 = 0.6, p = 0.4; D1MSN +
sulpiride versus D1MSN). (F) D1R activation nega-
tively modulated HFS-LTD at D1MSN synapses
(RM2W, F2,18 = 8, p = 0.003; D1MSN +SKF versus
D1MSN, p < 0.05; D1MSN +SKF versus D1MSN +
sulpiride, p < 0.01, Bonferroni).
(A and F) (Left) Data are presented as normalized
EPSP amplitude and normalized Rinp (mean ±
SEM). Black line shows eCB-LTD in D2MSN (A) and
HFS-LTD in D1MSN (D) from Figures 1B and 1C,
respectively, measured under control conditions
and reported here for reference. (Right) Bar
diagrams summare the ratios of post-HFS and
pre-HFS synaptic responses.glutamate release (Borycz et al., 2007). To test whether A1Rs
contribute to cell-type-specific synaptic plasticity at striatal cir-
cuits, we delivered HFS in the presence of the selective A1R
antagonist DPCPX (500 nM). Inhibition of A1R abolished LTD in
D1MSN (94% ± 5% of baseline, n = 13; p > 0.05; Figure 3C),
but not in D2MSN (49% ± 7% of baseline, n = 6; p < 0.05; Fig-
ure S3). DPCPX alone had no effect on basal glutamatergic
synaptic transmission in either neuronal subpopulation (D1MSN,
101% ± 5% of baseline, n = 10, p > 0.05; D2MSN, 104% ± 6%
of baseline, n = 6, p > 0.05, data not shown). This indicates a
lack of tonic inhibition by extracellular adenosine, which is1356 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The Authorsmost likely released in response to HFS
of cortical afferents. A second A1R antag-
onist, CPT (200 nM), also blocked LTD
at D1MSN (91% ± 6% of baseline, n = 6;
p > 0.05; Figure 3C).
We next tested the effect of the selec-
tive A1R agonist 50-Chloro-50-deoxy-
(±)-ENBA (ENBA, 200 nM) on synaptic
transmission at cortical connections toD1MSN. Activation of A1R produced a persistent depression of
synaptic responses generated by twin cortical stimuli (p1,
53% ± 14% of baseline; p < 0.05; Figure 3D). This synaptic
depression was rescued by the A1R antagonist DPCPX
(500 nM; p1, 82% ± 15% of baseline, n = 5; p > 0.05; Figure 3D).
Like LTD triggered by HFS (Figure 1C), the ENBA-induced LTD
was expressed presynaptically, as indicated by the increased
paired-pulse ratio (PPR) of synaptic responses that reversed
upon DPCPX application (PPR: baseline, 0.9 ± 0.07; ENBA,
1.7 ± 0.2; DPCPX, 1.13 ± 0.1; **p < 0.01; *p < 0.05; Figure 3D).
Collectively, these results suggest that adenosine triggers a
Figure 3. Adenosine A1 Receptor Mediates
LTD in D1MSN
(A–C) (Left) Time courses of normalized EPSP
amplitude and normalized Rinp (mean ± SEM).
(Right) Bar diagrams summarize the ratios of post-
HFS and pre-HFS synaptic responses. Synaptic
plasticity at cortical connections to D1MSN is
shown. Bath application of the NMDA receptor
antagonist DL-APV (A, 50 mM, white bar) and
mGlur2/3 antagonist LY341495 (B, 200 nM, gray
bar) did not affect plasticity of EPSPs compared to
the control conditions shown in Figure 1C (RM2W,
F1,10 = 0.03 p = 0.86, D1MSN + APV versus D1MSN;
F1,10 = 0.04, p = 0.84, D1MSN + LY341495 versus
D1MSN). Black line in (A) shows HFS-LTD in D1MSN
from Figure 1C. (C) Bath application of the A1R
antagonists DPCPX (500 nM, blue bar) or CPT
(200 nM, white bar) prevented HFS-LTD of EPSPs
in D1MSN (RM2W, F2,23 = 8, p = 0.003, D1MSN +
DPCPX versus D1MSN, p < 0.01; D1MSN + CPT
versus D1MSN, p < 0.05; D1MSN + DPCPX versus
D1MSN + CPT, p = 1, Bonferroni).
(D) Pharmacological A1R-mediated LTD at cortical
connections to D1MSN. (Left) Time course (mean ±
SEM) of the first peak (p1) and second peak (p2)
amplitudes of synaptic responses generated by
twin stimuli at a 100-ms interval. The A1R agonist
ENBA (200 nM, red bar) triggered a depression of
EPSPs that was rescued by the A1R antagonist
DPCPX (500 nM, blue bar; at the time points indi-
cated in the time course, baseline versus ENBA
p < 0.05; baseline versus DPCPX p > 0.05, RM1W,
Tukey). The gray area represents SEM values for
p2. (Right) Box-chart diagram indicates the PPRs
of baseline (black box), ENBA (red box), and
DPCPX (blue box) at the time points indicated in
the time course. The values represented are the
minimum,mean (bar inside the box), and themaximum. ENBA-induced LTDwas associated with increased PPR that reversed upon DPCPX application (baseline
versus ENBA p < 0.01; ENBA versus DPCPX p < 0.05, RM1W, Tukey). (Insets) Averaged recordings (ten traces) before (black) and after the application of ENBA
(red) or DPCPX (blue). PPR was expressed as the ratio between the amplitude of the second and the first EPSPs.form of HFS-LTD at cortico-D1MSN synapses that requires the
activation of presynaptic A1R.
In summary, in response to cortical stimulation, LTD at con-
nections to D2MSN requires the activation of CB1R and D2R,
whereas HFS-LTD at connections to D1MSN does not. HFS-
LTD in D1MSN is instead reduced when postsynaptic D1R is
co-activated and is dependent on presynaptic A1R. Postsyn-
aptic dopaminergic signaling thus influences these two forms
of LTD in opposite ways. That is, in D2MSN, intracellular cascades
downstream of D2R could facilitate the induction of eCB-LTD by
promoting eCB biosynthesis (Lerner and Kreitzer, 2012). In
D1MSN, activation of signaling cascades downstream of D1R
could dynamically suppress LTD by counteracting the effect of
presynaptic A1R that reduces glutamate release.
Corticostriatal LTD in D2MSN and D1MSN of
6-OHDA-Lesioned Mice
This cell-type-specific, dopaminergic regulation of LTDs may be
lost upon dopaminergic denervation in PD. In this case, at
cortical synapses to D2MSN in the disease state, D2R would
not contribute to eCB biosynthesis, and eCB-LTD would be
impaired (Lerner and Kreitzer, 2012). In contrast, at cortical syn-Cell Repapses to D1MSN, presynaptic induction mechanisms of A1R-
mediated LTD would be unaffected. What might be lost in vivo
is the antagonist interaction between presynaptic A1R- and
postsynaptic D1-mediated signaling in modulating the strength
of cortical inputs. Together, these pathway-specific effects
might lead to dysfunctional integration of D2MSN and D1MSN
activity and, ultimately, to motor deficits.
As a first step to test these hypotheses, we examined cortico-
striatal synaptic plasticity in the unilateral 6-OHDA-lesioned
mouse model of PD (Schwarting and Huston, 1996). Upon
HFS, LTD was indeed impaired at cortical connections to
D2MSN in 6-OHDA-lesioned mice (6-OHDAipsi, 91% ± 5% of
baseline, n = 9; p > 0.05; Figure 4A) compared to sham animals
(Shamipsi, 52% ± 8% of baseline, n = 5; p < 0.05; Figure 4A).
These results are consistent with previous studies showing
the loss of eCB-mediated LTD in D2MSN of 6-OHDA mice
upon intrastriatal HFS of excitatory terminals (Kreitzer and Mal-
enka, 2007; Lerner and Kreitzer, 2012). In contrast, in D1MSN of
6-OHDA- and sham-lesioned mice, HFS-LTD was of compara-
ble magnitude (6-OHDAipsi, 61% ± 7% of baseline, n = 11,
p < 0.05; Shamipsi, 65% ± 7% of baseline, n = 5, p < 0.05;
Figure 4B).orts 13, 1353–1365, November 17, 2015 ª2015 The Authors 1357
Figure 4. SK Channel Inhibition Dichoto-
mously Modulates Corticostriatal LTD at
D2MSN and D1MSN Synapses of 6-OHDA-
Lesioned Mice
(A) Upon dopamine depletion, LTD was impaired
at glutamatergic synapses of D2MSN 6-OHDA
mice compared to sham animals (RM2W, F1,12 =
20, p = 0.0007; D2MSN 6-OHDAipsi versus D2MSN
Shamipsi, p < 0.01, Bonferroni).
(B) In contrast, induction of HFS-LTD was
unaffected in D1MSN 6-OHDAmice (RM2W, F1,14 =
0.8, p = 0.39, D1MSN 6-OHDAipsi versus D1MSN
Shamipsi).
(C) Bath application of the SK channel inhibitor
apamin (100 nM, green bar) reinstated a form of
LTD at D2MSN synapses of 6-OHDA-lesionedmice,
whichwassensitive to theCB1RantagonistAM251
(4 mM, white bar; RM2W, F2,21 = 7.3, p = 0.0038;
D2MSN 6-OHDAipsi + APA versus D2MSN
6-OHDAipsi, p < 0.05; D2MSN 6-OHDAipsi + APA
versus D2MSN 6-OHDAipsi + APA/AM251, p < 0.01;
D2MSN 6-OHDAipsi + APA/AM251 versus D2MSN
6-OHDAipsi, p=1,Bonferroni).Red lineshowseCB-
LTD in D2MSN 6-OHDA mice, as reported in (A).
(D) Exposure to apamin abolished HFS-LTD in
D1MSN 6-OHDAipsi mice. This effect was averted
by including the MEK/ERK inhibitor PD0325901
(20 nM) in the postsynaptic neuron (RM2W, F2,20 =
12, p = 0.0003; D1MSN 6-OHDAipsi + APA versus
D1MSN 6-OHDAips, p < 0.001; D1MSN 6-OHDAipsi +
APA versus D1MSN 6-OHDAipsi + APA +
PD0325901, p < 0.01; D1MSN 6-OHDAipsi + APA +
PD0325901 versus D1MSN 6-OHDAipsi, p = 1,
Bonferroni). Blue line indicates HFS-LTD in D1MSN
6-OHDA mice, as reported in (B).
Data are presented as normalized EPSP ampli-
tude and normalized Rinp (mean ± SEM). Insets
represent superimposed averaged recordings (ten
traces) before (black line) and after (red line) the
delivery of the HFS protocol.Inhibition of SK Channel Activity Dichotomously
Modulates LTD at Striatal Pathways in PD Model Mice
To determine whether PD motor deficits are directly linked to a
dysfunctional coordination of presynaptic and postsynaptic
mechanisms of plasticity at both striatal pathways, we designed
a rescue experiment. First, we devised a method to recapitulate
the postsynaptic regulation of eCB-LTD and A1R-LTD at striatal
pathways in PDmodel mice, and thenwe assessed the effects of
this rescue on motor behavior.
ActivatingCa2+-dependent intracellular signaling cascades that
act downstream of D2 and D1 dopamine receptors would modu-
late the activity of the twopathways, bypassing the need for dopa-
mine itself. For this purpose, we targeted the activity of the small-
conductance Ca2+-activated K+ (SK) channels. Through negative
feedback, inhibition of SK channel activity enhances Ca2+ signals
triggered by back-propagating action potentials (Tonini et al.,
2013) and by synaptic activation of NMDAR (Bloodgood and
Sabatini, 2008) in several brain regions. This negative feedback
also applies to the postsynaptic Ca2+ transients evoked by HFS
stimulation of cortical afferents to D2MSN and D1MSN (Figure S4).
In D2MSN, inhibition of SK channels facilitates the Ca
2+-depen-
dent release of eCBs and eCB-LTD, bypassing the postsynaptic1358 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The Auactivation of D2R (Nazzaro et al., 2012). In D1MSN, voltage-
dependent Ca2+ influx activates the ERK signaling pathway
and ERK-mediated plasticity (Cahill et al., 2014; Girault et al.,
2007); the postsynaptic ERK cascade has been shown to in-
crease the synaptic responsiveness of D1MSN (Cerovic et al.,
2015; Pascoli et al., 2012). Inhibition of SK channel activity could
be thus used to boost the activation of the ERK signaling
pathway independent of D1R.
In this view, inhibition of SK channel activity should restore
eCB-LTD in D2MSN and counteract LTD in D1MSN in 6-OHDA
mice.
Indeed, bath application of the selective SK channel inhibitor
apamin (APA, 100 nM) during HFS rescued LTD in D2MSN of
6-OHDAipsi mice (D2MSN 6-OHDAipsi + APA, 52% ± 11% of
baseline, n = 8; p < 0.05; Figure 4C). The effect of apamin was
mediated by the activation of CB1R, since applying the antago-
nist AM251 prevented the rescue (D2MSN 6-OHDAipsi + APA/
AM251, 97% ± 10% of baseline, n = 7; p > 0.05; Figure 4C).
Consistent with our hypothesis, SK channel inhibition at
D1MSN 6-OHDAipsi synapses had the opposite effect. In the pres-
ence of apamin, HFS did not result in LTD (D1MSN 6-OHDAipsi +
APA, 91% ± 5%of baseline, n = 6; p > 0.05; Figure 4D). Apamin’sthors
Figure 5. SK Channel Inhibition Selectively
Potentiates the ERK Signaling Cascade in
D1MSN
(A) (Top) Schematic representation of the unilateral
intracerebral (i.c.) injection of apamin (0.08 ng in
0.5 ml) or vehicle. (Bottom) Photomicrograph
shows a TH-stained coronal section depicting the
cannula track (marked by the arrowhead) within
the ipsilateral DLS of a 6-OHDA-lesioned mouse.
(B and C) Confocal laser scanning immunofluo-
rescent detection of apamin-induced phosphory-
lation of ERK and protein S6 in the ipsilateral DLS
of 6-OHDA-lesioned mice. (B) Representative im-
ages and quantification (mean ± SEM) of pERK-
(left, green) and pS6- (right, green) positive cells in
C57/Bl6J mice are shown (pERK, vehicle n = 11,
apamin n = 10, p < 0.01, t test; pS6, vehicle n = 11,
apamin n = 10, p < 0.001, t test). The neuronal
marker NeuN is in red. (C) pERK- (left, gray)
and pS6- (right, gray) positive cells in D1MSN
and D2MSN of drd1a-tdTomato
tg (D1, red)/drd2-
EGFPtg (D2, green) mice are shown (vehicle n = 8,
apamin n = 9; mean ± SEM). In the ipsilateral DLS
of drd1a-tdTomatotg/drd2-EGFPtg mice infused
with apamin or vehicle, two-way ANOVA, Bonfer-
roni’s post hoc test, revealed a significant effect of
the treatment in D1MSN, but not in D2MSN (pERK,
F1,30 = 5, p = 0.04; D1MSN, vehicle versus apamin
p < 0.01; D2MSN, vehicle versus apamin p = 1; pS6,
F1,30 = 8, p = 0.007; D1MSN, vehicle versus apamin
p < 0.01; D2MSN, vehicle versus apamin p = 0.5).
Note the colocalization of pERK and pS6 and
D1MSN (red) (***p < 0.001 and **p < 0.01).effect was due to the activation of ERK signaling in the post-
synaptic D1MSN; including the MEK/ERK pathway inhibitor
PD0325901 (20 nM) in the intracellular recording solution
restored LTD in D1MSN (D1MSN 6-OHDAipsi + APA/PD0325901,
69% ± 11% of baseline, n = 6; p < 0.05; Figure 4D). To further
investigate how presynaptic mechanisms of LTD and postsyn-
aptic ERK signaling interact in D1MSN of PD mice, we tested
the effect of co-application of apamin with the A1R antagonist
DPCPX. In D1MSN 6-OHDAipsi neurons, this manipulation did
not shift synaptic plasticity further toward LTP (D1MSN
6-OHDAipsi + APA/DPCPX, 101% ± 7% of baseline, n = 7; p >
0.05; data not shown), possibly because of impaired molecular
mechanisms underlying the expression of synaptic potentiation
in PD mice (Calabresi et al., 2000; Picconi et al., 2003).
Collectively, these results suggest that, at D1MSN of PD
mice, SK channel inhibition counteracts LTD by promoting
ERK cascade activation.
Inhibition of SK Channel Activity In Vivo Specifically
Activates ERK Signaling in D1MSN
To confirm that SK channel modulation affects ERK signaling in
striatal circuits and to test whether this effect is cell-type spe-
cific, we administered apamin in vivo. We infused either apamin
(0.08 ng/0.5 ml intracerebrally [i.c.]) or saline in the ipsilateral DLS
of 6-OHDA-lesioned mice (Figure 5A). After 10 min, we moni-
tored phosphorylation of both ERK1/2 and the downstream
target ribosomal protein S6 at Ser235/236, a site known to be
a direct target of activated ERK (Cerovic et al., 2015).Cell RepApamin infusion significantly increased thenumber ofphospho-
ERK (pERK)-positive cells (vehicle, 4% ± 2%, n = 11; apamin,
13%± 2%, n= 10; p <0.01; Figures 5BandS5A) andpS6-positive
cells in 6-OHDA-lesioned mice (vehicle, 28% ± 3%, n = 11; apa-
min, 47% ± 4%, n = 10; p < 0.001; Figures 5B and S5A). To deter-
mine the cell-type specificity of this effect, we infused apamin in
the ipsilateral DLS of drd1a-tdTomatotg/drd2-EGFPtg 6-OHDA-
lesioned animals. The number of pERK- and pS6-positive D1MSN
increased with apamin (pERK, vehicle, 5% ± 2%, n = 8; apamin,
17%± 5%, n = 9; p < 0.01; pS6, vehicle, 7% ± 1%, n = 8; apamin,
27%±5%,n=9;p<0.01;Figures5CandS5B). Incontrast, almost
nopERK-positiveD2MSNweredetectable in either vehicle- or apa-
min-treated mice (vehicle, 0.1% ± 0.1%, n = 8; apamin, 0.2% ±
0.1%, n = 9; p < 0.05; Figures 5C and S5B), nor were there any
differences in the number of pS6-positive D2MSN upon apamin
infusion (vehicle, 39% ± 6%, n = 8; apamin, 46% ± 4%, n = 9;
p > 0.05; Figures 5C and S5B). The number of pS6-positive cells
appeared to directly correlate with the number of pERK-positive
cells specifically in the D1MSN subpopulation (Figure 5C), consis-
tent with previous observations (Bonito-Oliva et al., 2013).
Overall, these results demonstrate that inhibition of striatal SK
channel activity selectively activates the ERK signaling cascade
in D1MSN.
Activating eCB and ERK Signaling In Vivo Alleviates
Motor Abnormalities in PD Model Mice
Reminiscent of dopamine regulation, inhibition of SK channel ac-
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in PD model mice. That is, SK channel inhibition rescues LTD
in D2MSN by boosting the eCB system, while counteracting
LTD in D1MSN by promoting the activation of postsynaptic ERK
signaling. If these synaptic effects are directly related to motor
behavior, inhibiting SK channel activity in the ipsilateral DLS of
6-OHDA mice in vivo should rescue some of the motor deficits.
To test this, we assessed the impact of a single in vivo apamin
infusion in the DLS on distinct forms of motor behaviors in PD
mice.
In Vivo Inhibition of Striatal SK Channel Activity Reduces
Asymmetric Motor Behavior and Enhances Motor
Responses Induced by D1-Dopaminergic Drugs
In the unilateral 6-OHDA-lesioned mouse model, asymmetric
dopamine depletion results in ipsiversive spontaneous rotations
of the body and drug-induced contralateral rotations that are
widely used to assess the effectiveness of treatment strategy
(Schwarting and Huston, 1996). We tested whether rescuing
the regulation of corticostriatal synapses (by inhibiting SK chan-
nels with apamin) could reduce the number of net ipsilateral
rotations or potentiate contraversive turning behavior upon co-
administration with dopaminergic agonists.
In vivo infusion of apamin in the ipsilateral DLS (0.08 ng/0.5 ml
i.c.) indeed significantly reduced net ipsiversive spontaneous ro-
tations of 6-OHDA-lesioned mice (p < 0.001, t test; Figure 6A).
We then assessed whether this behavioral rescue by SK channel
inhibition was directly linked to eCB or ERK signaling. We first
measured the number of spontaneous rotations upon infusing
apamin and apamin plus the CB1R antagonist AM251 (0.5 ng/
0.5 ml i.c.). Manipulating the eCB system did not change the
rescuing effect of apamin (p > 0.05, Tukey; Figure 6B) and had
no effect alone (p > 0.05; Figure 6B). In contrast, co-injection
of apamin with the MEK/ERK inhibitor PD0325901 (5 pg/0.5 ml
i.c.) fully prevented the rescuing effect of apamin (p < 0.001,
Tukey; Figure 6C). PD0325901 alone did not alter rotational
behavior (p > 0.05, Tukey; Figure 6C).
Finally, we tested whether A1R antagonism, which similar to
apamin prevents LTD in D1MSN (Figure 3C), affected the number
of net ipsilateral rotations in the PDmodel. Alone, the A1R antag-
onist DPCPX (0.07 ng/0.5 ml i.c.) indeed recapitulated the behav-
ioral effect of apamin (p < 0.05, Tukey; Figure 6D). Co-injecting
apamin with DPCPX did not further increase the number of con-
traversive movements (p > 0.05, Tukey; Figure 6D). Net sponta-
neous locomotor activity was similar in the different cohorts of
mice (Figures S6A and S6B).
We also evaluated the effect of apamin on contraversive
turning behavior in response to a systemic low dose of the
non-selective D1/D2 agonist apomorphine (0.1 mg/kg subcuta-
neously [s.c.]; Figure 6E). Apamin injection increased the number
of apomorphine-induced rotations compared to vehicle-injected
mice (p < 0.05, Tukey; Figure 6E). Apamin had no effect on
contralateral rotations induced by administration of the selective
D2 agonist pramipexole (1 mg/kg intraperitoneally [i.p.]; p > 0.05,
Tukey; Figure S6C). In contrast, apamin did potentiate contralat-
eral rotations induced by systemic administration of the selective
D1 receptor agonist SKF38393 (SKF, 10 mg/kg i.p; p < 0.05,
Tukey; Figure 6F). This effect was not mediated by the activation
of CB1R, as it was insensitive to the co-injection of apamin with
AM251 (0.5 ng/0.5 ml i.c.; p < 0.05, Tukey; Figure 6F).1360 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The AuTogether, these results suggest that the rescue effect of
modulating SK channels on turning behavior may occur through
D1MSN activity, via the ERK-dependent counteraction of A1R-
mediated LTD.
In Vivo SKChannel Inhibition in theDLS Improves Skilled
Motor Deficits
We next evaluated the effects of in vivo SK channel inhibition on
skilled motor behavior, which requires repetitive training para-
digms for motor learning and fine movement control (Costa
et al., 2004). First, we tested the duration of the inhibitory effect
of a single apamin infusion in the DLS on the SK-mediated cur-
rent (Figure S7). We found that apamin’s effect lasted at least
24 hr (Figures S7A and S7B).
The motor abilities of 6-OHDA- and sham-lesioned mice were
assessed by fixed-speed (FSRR) and accelerated (ARR) rotarod
tests (Monville et al., 2006). In FSRR (15 rpm, 120 s maximum
time), performances were significantly reduced in 6-OHDA
mice compared to sham animals (6-OHDA, 57 ± 3 s; sham,
111 ± 2 s; p < 0.001, t test; Figures 7A and 7B). Apamin infusion
improved motor performance of 6-OHDA-lesioned mice when
tested 1, 24, and 48 hr after the injection (p < 0.01, Tukey; Fig-
ure 7A). Injection with vehicle had no effect on performance
(p > 0.05; Figure 7A).
The effect of apamin was prevented by the CB1R antagonist
AM251 (0.5 ng/0.5 ml i.c.; p > 0.05, Tukey; Figure 7A), which alone
had no behavioral effect (p > 0.05, Tukey; Figure 7A). Collec-
tively, mice receiving apamin had a significantly improved
FSRR performance compared to the other groups (2WRM,
Holm-Sidak: treatment, F3,75 = 4.7, p = 0.0045; session,
F2,150 = 0.09, p = 0.9; session 3 treatment, F6,150 = 1.8, p =
0.09). Consistent with the duration of the in vivo inhibitory effect
of apamin on SK channel activity (Figures S7A and S7B), we
observed a significant motor improvement for up to 24 hr after
drug infusion. After 7 days, performance on the rotarod no longer
varied among groups (latency to fall, Veh_Veh, 56 ± 8 s, n = 22;
APA_Veh, 63 ± 9 s, n = 24; APA_AM251, 51 ± 10 s, n = 16;
Veh_AM251, 53 ± 10 s, n = 17; p > 0.05; data not shown).
The pharmacological treatments had no behavioral effects in
sham-lesioned animals (2WRM, Holm-Sidak: treatment, F3,40 =
1.4, p = 0.3; session, F2,80 = 0.8, p = 0.4; treatment 3 session,
F6,80 = 0.7, p = 0.6; Figure 7B).
In vivo apamin infusion had a similar rescuing effect in the ARR
test (4–40 rpm, 0.12 rpm/s, 300 s). 6-OHDA-lesioned mice,
but not sham animals, showed improved motor performance
upon apamin injection, and this was CB1R mediated (2WRM,
Holm-Sidak: 6-OHDA, treatment, F3,70 = 3.2, p = 0.03; session,
F2,140 = 1.14, p = 0.32; treatment 3 session, F6,140 = 0.9, p =
0.5; and sham, treatment, F3,39 = 0.3, p = 0.8; session, F2,78 =
0.8, p = 0.5; treatment 3 session, F6,78 = 0.6, p = 0.8;
Figure S7C).
These results suggest that in vivo inhibition of SK channel ac-
tivity improves skilled motor behavior through an eCB-mediated
mechanism. To confirm this, we repeated the behavioral tests
while co-injecting apamin and the PLD inhibitor CAY10594
(CAY, 22 ng/0.5 ml i.c.), which abolishes eCB plasticity at cor-
tico-D2MSN synapses (Figure 2A). Inhibiting the activity of PLD
prevented the rescuing effects of SK channel inhibition
(2WRM, Holm-Sidak: FSRR, treatment, F3,72 = 3.9, p < 0.05;thors
Figure 6. Effect of In Vivo Modulation of SK
Channel Activity in the DLS of 6-OHDA-
Lesioned Mice on Rotational Behavior
(A–D) (Top) Schematic of the pharmacological
regimen of DLS injections (i.c.) and behavioral
tests. (Bottom) Time courses (left) of spontaneous
turning behavior computed every 10min for 60min
and bar diagram (right) of net averaged rotations
(contralateral-ipsilateral tight 180 rotations of
the body) under the different pharmacological
treatments are shown. Turns in the direction
contralateral to the lesion are indicated by positive
figures on the y axis.
(A) Spontaneous net ipsilateral rotations in
6-OHDA-lesioned mice upon apamin or vehicle
infusion in the DLS are shown (APA, 16 ± 4,
n = 15; vehicle 48 ± 7, n = 15).
(B) Behavioral effect of co-injection of apamin
with the CB1R antagonist AM251, AM251 alone,
or their vehicles is shown (APA_Veh, 21 ± 4,
n = 17; Veh_Veh, 54 ± 4, n = 17; APA_AM251,
27 ± 7, n = 9; Veh_AM251, 63 ± 10, n = 10).
(C and D) The time courses (left) and 60 min-
binning (right, bar diagrams) of spontaneous
turning behavior from mice infused with vehicle or
with apamin displayed in (B) are reported in (C) and
(D) for comparison. (C) Behavioral effect of co-
injection of apamin with PD0325901, PD032590
alone, or their vehicles is shown (APA_PD, 65 ±
10, n = 12; Veh_PD, 58 ± 10, n = 13). (D) Spon-
taneous net ipsilateral rotations in 6-OHDA-
lesioned mice following a single injection of the
A1R antagonist DPCPX or co-injection of DPCPX
with apamin (Veh_DPCPX, 29 ± 5, n = 11;
APA_DPCPX, 19 ± 8, n = 11).
(E and F) (Top) Order of pharmacological
regimen of apamin injection (i.c.), administration
of apomorphine (i.p.) (E) or SKF38393 (i.p.) (F),
AM251 infusion (i.c.) (F), and behavioral tests.
(Bottom) Time course (left) of motor activation
computed every 5 min for 25 min (E) or every 5 min
for 45 min (F) and bar diagram (right) of net aver-
aged rotations are shown. (E) Effect of apamin
infusion on apomorphine-induced contralateral
rotations is shown (contralateral-ipsilateral tight
360 rotations of the body, vehicle, 103 ± 15,
n = 20; APA, 165 ± 25, n = 12, p < 0.05). (F) SKF-
induced contraversive rotations upon apamin and/
or AM251 infusion are shown (Veh_Veh, 124 ± 50,
n = 11; APA_Veh, 248 ± 38, n = 13; Veh_AM251,
134 ± 50, n = 8; APA_AM251, 259 ± 34, n = 13).
***p < 0.001, **p < 0.01, *p < 0.05.session, F2,144 = 2.9, p = 0.06; treatment 3 session, F6,144 = 0.9,
p = 0.5; and ARR, treatment, F3,72 = 3.0, p < 0.05; session,
F2,144 = 1.7, p = 0.2; treatment 3 session, F6,144 = 0.7, p = 0.7;
Figures S7D and S7E). Spontaneous locomotor activity was un-
changed in 6-OHDA- and sham-lesioned mice when tested 1,
24, and 48 hr after drug infusion (Figures S7F and S7G).
Our results show that synaptic eCB signaling is required to
gate LTD at cortical connections to D2MSN (Figure 1B), impaired
upon dopaminergic denervation (Figure 4A) and reinstated at
these specific synapses following inhibition of SK channel activ-
ity (Figure 4C), suggesting that eCB-LTD in D2MSN plays a critical
role in producing coordinated behavior.Cell RepWe cannot exclude, however, that the ERK-mediated
increase in synaptic responsiveness of D1MSN with apamin
(Figures 4D and 5) could contribute to improving motor perfor-
mance of PD mice on the rotarod by alleviating the ipsilateral
bias of motion (Figure 6). Indeed, in the FSRR test, the effect
of apamin (2WRM, Holm-Sidak: treatment, F3,66 = 5, p =
0.003; session, F2,132 = 1, p = 0.3; session 3 treatment,
F6,132 = 2, p = 0.06) was dampened by the co-injection
of PD0325901 (5 pg/0.5 ml i.c; p < 0.05 at 1 hr; Figure 7C).
These results indicate that apamin improves the rotarod
performance of PD mice through a mechanism involving
the concurrent activation of the eCB system and the ERKorts 13, 1353–1365, November 17, 2015 ª2015 The Authors 1361
Figure 7. Effect of In Vivo Modulation of SK Channel Activity in the
DLS on Skilled Motor Performance
(A) Performance of 6-OHDA-lesionedmice subjected to a fixed speed (15 rpm)
rotarod test (FSRR) following intracerebral injection of apamin (p < 0.01). The
effect of apamin was prevented by co-administration of the CB1R antagonist
AM251 (p > 0.05). No changes in performance were observed in mice injected
with saline (p > 0.05) or with AM251 (p > 0.05).
(B) No changes in rotarod performance were observed in the different cohorts
of sham-lesioned mice (p > 0.05).
(C) Skilledmotor performance of 6-OHDA-lesionedmice in the FSRR test upon
a single infusion of the MEK/ERK inhibitor PD0325901, applied in isolation
(p > 0.05) or co-injected with apamin, is shown (p = 0.04).
(D) Performance of 6-OHDA-lesioned mice in the FSRR test upon a single
infusion of the A1R antagonist DPCPX (p > 0.05). Performance of 6-OHDA-
lesioned mice infused with saline/DMSO or with apamin and displayed in (C) is
reported here for comparison (dotted lines).
*, , xp < 0.05 versus APA_Veh (RM1W, Tukey).cascade. If this is the case, we would expect that mimicking
the synaptic effect of ERK activation in D1MSN by exclusively
blocking A1R should not be sufficient to improve skilled
motor behavior. Consistent with this, we found that 6-OHDA-
lesioned mice infused with DPCPX alone (0.07 ng/0.5 ml i.c.,
Veh_DPCPX) did not improve their motor abilities; they per-
formed significantly worse than mice receiving apamin
(2WRM, Holm-Sidak: FSRR, treatment, F2,51 = 6, p = 0.006;
session, F2,102 = 3, p = 0.08; session 3 treatment, F4,102 =
1, p = 0.4; Veh_DPCPX versus Veh_Veh, p > 0.05; Veh_DPCPX
versus APA_Veh, p < 0.05, at 1–24 hr; Figure 7D). Neither
PD0325901 nor DPCPX affected spontaneous locomotor ac-
tivity (Figure S7H).
Taken together, our data suggest that coordinated eCB and
ERK signaling is required to enabling fine movement control dur-
ing skilled motor behavior.1362 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The AuDISCUSSION
This study demonstrates that, in an experimental model of PD,
the concomitant and cell-type-specific activation of the eCB
and ERK signaling cascades in the DLS normalizes striatal cir-
cuitry and restores effective control of motor functions. These
cascades can be activated by the manipulation of SK channel
activity, which modulates eCB-LTD in D2MSN and adenosine-
mediated LTD in D1MSN. Our results are, therefore, consistent
with a model in which the synaptic neuromodulators dopamine,
eCBs, and adenosine are integrated and shape motor behavior
by concurrently regulating mechanisms of synaptic plasticity in
both MSN subpopulations.
HFS-LTD in D2MSN and D1MSN
HFS of cortical afferents to the DLS induces LTD in both MSN
subpopulations. In contrast to LTD at cortical connections to
D2MSN, the gating of HFS-LTD at D1MSN is independent of the
activation of eCB and D2R signaling and unaffected by dopa-
mine denervation. In this context, our results inform the still-
debated issue of whether eCB-LTD is equally inducible in both
D2MSN and D1MSN (Adermark and Lovinger, 2007; Bagetta
et al., 2011; Kreitzer and Malenka, 2007; Nazzaro et al., 2012;
Shen et al., 2008; Wang et al., 2006).
There is a general consensus that eCB-LTD can be reliably
induced at glutamatergic synapses on identified D2MSN indepen-
dently of the experimental paradigm (Adermark and Lovinger,
2007; Wang et al., 2006). In identified D1MSN, HFS-LTD is not
inducible using intrastriatal stimulation (Kreitzer and Malenka,
2007). However, this observation is challenged by studies
showing a form of LTD in D1MSN that is dependent on CB1 and
D2 receptors (Adermark and Lovinger, 2007; Bagetta et al.,
2011) and blocked following striatal dopamine denervation
(Bagetta et al., 2011).
Results obtainedwhenplasticity is evokedby intrastriatal stim-
ulation and those gained in this study by cortical stimulation may
not be directly comparable. Indeed,monoamines (dopamine and
serotonin) and thalamic glutamate released upon intrastriatal
stimulation might affect the direction of synaptic plasticity in
D1MSN (Wuet al., 2015). This is likely not to be the case upon stim-
ulation of cortical layer V (Fino et al., 2005).Moreover, themajority
of the studies investigating striatal HFS-LTD have been per-
formed by voltage-clamp recordings (Adermark and Lovinger,
2007; Kreitzer andMalenka, 2007;Wang et al., 2006), using intra-
cellular solutions containing high Cs+ and TEA+ concentrations,
thus blocking potassium conductance. These experimental con-
ditions could prevent differential potassium channel activation in
D1MSN and D2MSN during stimulation and, hence, possibly mask
differences in the threshold for induction of synaptic plasticity be-
tween the two MSN subpopulations. We favor the idea that the
threshold for eCB production could be higher in D1MSN than
D2MSN. Indeed, we found that when the biosynthesis of eCBs
was facilitated by the pharmacological stimulation of mGlur1/
5R signaling, cortico-D1MSN synapses expressed a form of
CB1R-dependent LTD, consistent with recent observations (Wu
et al., 2015). Thus, while eCB-LTD may not be cell-type specific
per se, the threshold for the induction of this form of plasticity
can be modulated in a cell-type-specific manner.thors
Adenosine-Mediated LTD at Cortico-D1MSN Synapses
One key question is which neuromodulatorymechanisms govern
LTD at D2MSN and D1MSN in response to different activity pat-
terns of convergent synaptic inputs and ultimately fine-tune mo-
tor control. We show that upon HFS of cortical afferents, eCB
signaling governs LTD at D2MSN, whereas adenosine governs
LTD at D1MSN. This role of adenosine at striatal circuits was
previously unknown. The source of adenosine may be the post-
synaptic MSN or it may originate from the catabolism of ATP co-
released with glutamate from glial and glutamatergic terminals
upon HFS (Pascual et al., 2005).
In our conditions, adenosine-mediated LTD appears to be
specifically expressed at cortical connections to D1MSN and re-
quires the activation of A1Rs. In the striatum, A1Rs are found
at corticostriatal afferents, where they negatively modulate glu-
tamatergic neurotransmission, and on the postsynaptic D1MSN
(Ferre´ et al., 1997). Our data, that both HFS-LTD and pharmaco-
logical A1R-dependent LTD at D1MSN show a presynaptic locus
of expression, support a central role for presynaptic A1R in the
induction of LTD at cortico-D1MSN synapses. We cannot
exclude, however, that activation of postsynaptic A1R might
be involved in the modulation of this form of plasticity through
direct antagonism of D1R. In striatal homogenates, A1R inhibits
the D1R-induced activation of adenylyl cyclase, and this also
may occur in D1MSN where A1R and D1R co-localize (Ferre´
et al., 1997). By dampening the D1R-mediated activation of Gs
signaling pathways that shift plasticity toward potentiation
(Lerner and Kreitzer, 2011), activation of postsynaptic A1R could
synergize with presynaptic A1R, thus bolstering the expression
of LTD at cortico-D1MSN synapses.
Behavioral Relevance of Cell-Type-Specific Regulation
of Synaptic Mechanisms of Plasticity
We provide evidence that restoring the functional integration
of presynaptic and postsynaptic mechanisms of plasticity in
D2MSN and D1MSN directly improves motor behavior in a mouse
model of PD. In PDmice, the inhibition of SK channels in the DLS
rescued the disease-linked deficits in eCB-LTD in D2MSN
neurons. The same treatment increased the synaptic respon-
siveness of D1MSN via postsynaptic ERK activation, thus coun-
teracting A1R-LTD. Inhibiting SK channel activity in the DLS
in vivo alleviated specific motor abnormalities, supporting that
differential modulation of synaptic mechanisms of plasticity at
striatal pathways affects behavior (Figure S9).
The synaptic and behavioral effects of the SK-mediated mod-
ulation of the ERK signaling cascade in D1MSN of PD mice are
fundamental points of novelty in our findings. The Ras-ERK
signaling cascade is regulated by upstream neuron-specific
guanine nucleotide exchange factors, including the Ca2+-depen-
dent exchange factor Ras-GRF1, which promotes the induction
of LTP at corticostriatal synapses in D1MSN, but not in D2MSN
(Cerovic et al., 2015). Fine-tuning intracellular Ca2+ in D1MSN by
inhibiting SK channels might promote ERK signaling activation
via RasGRF1.
We show that in vivo inhibition of SK channels with apamin in
the DLS of PD mice is sufficient to reduce pathological asym-
metric turning behavior. Inhibiting the ERK cascade prevents
this rescue. Furthermore, in vivo antagonism of A1R, which hasCell Repa similar effect to apamin on LTD in D1MSN, also recapitulates
the effects of apamin on behavior. Apamin also enhances motor
responses to the selective D1 agonist SKF38393 in the PD
mouse model. Collectively, this evidence helps to build a model
in which increasing the synaptic responsiveness of D1MSN res-
cues asymmetric turning behavior. In the PD state, characterized
by striatopallidal hyperactivity and striatonigral hypoactivity
(DeLong and Wichmann, 2009), the SK-mediated modulation
of D1MSNmay equilibrate the coordinated outputs of the two pro-
jection pathways to produce spontaneous contraversive move-
ments (Tecuapetla et al., 2014).
In vivo administration of apamin in the DLS improves skilled
motor behavior through a mechanism that requires intact eCB
biosynthetic machinery and CB1R function. This strongly sup-
ports the direct relationship between eCB-LTD and this specific
motor ability. Nevertheless, in vivo ERK antagonism dampens
the rescuing effect of apamin. This suggests that coordinated
eCB and ERK signaling is required to enable finemovement con-
trol on the rotarod.
It has been reported previously that systemic co-administra-
tion of an eCB degradation inhibitor and a D2 agonist partially
rescues motor deficits in PD mice (Kreitzer and Malenka,
2007). Here, apamin infusion in the DLS improves motor function
and skilled motor learning in the PD mouse model, without the
need for dopaminergic stimulation. The numerous dissimilarities
in the animal models (acute bilateral versus chronic dopamine-
depleted mice) and in the treatment (systemic versus local)
may account for this difference. Additionally, in this work, mod-
ulation of SK channel activity in the DLS concurrently engages
synaptic mechanisms of plasticity (i.e., eCB and ERK signaling)
in both D2MSN and D1MSN, whereas in Kreitzer and Malenka
(2007) study only the striatopallidal pathway was targeted.
Recent work has demonstrated that D1MSN and D2MSN act
simultaneously during action initiation (Cui et al., 2013), rather
than sequentially starting and stopping movement, as previously
inferred (Albin et al., 1989). In PD, which is characterized by def-
icits in initiating and terminating sequences of movements,
dopamine depletion may affect the coordinated activity of spe-
cific neural ensembles that activate or inhibit individual cortical
motor programs (Cui et al., 2013). Since SK channels open in
response to elevation of intracellular Ca2+, we propose that the
SK-mediated feedback modulation of voltage-dependent Ca2+
influx is particularly effective at modifying behavior (Nazzaro
et al., 2012; this study), as this modulation may preferentially
occur when convergent cortical activity brings striatal neurons
into depolarized up states. This may allow for regulation of
cell-type-specific Ca2+-dependent intracellular pathways, spe-
cifically in cortically entrained striatal synapses. In PD model
mice, thismight re-establish the correct processing of behavioral
information from the cerebral cortex through the basal ganglia
circuits. In this view, striatal SK channels represent a promising
non-dopaminergic target to concurrently regulate striatopallidal
and striatonigral circuitry in basal ganglia disorders.EXPERIMENTAL PROCEDURES
All procedures involving animals were carried out in accordancewith the Italian
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Dopaminergic Lesion
Mice were injected with 6-OHDA HBr (3.5 mg/ml) into the right medial forebrain
bundle (MFB). Severity of dopamine denervation was estimated 9–14 days
later by computing the number of ipsilateral over total spontaneous rotations
of the body in 6-OHDA- and sham-lesioned mice. Only mice displaying a ratio
of ipsilateral/total tight rotations >90% were considered for further experi-
ments (mean ± SEM; 45 min; 6-OHDA, 99% ± 0.1%, n = 498; sham, 49% ±
1.4%, n = 70; 6-OHDA versus sham, p < 0.001, t test). The extent of the
lesion was later assessed by analyzing tyrosine hydroxylase (TH) levels in
the striatum with immunohistochemistry. Only lesions >80% were included
in the analysis (mean ± SEM; 6-OHDA, 94.2% ± 0.3%, n = 498; sham,
1.7% ± 0.7%, n = 70; 6-OHDA versus sham, p < 0.001, t test).
Intrastriatal Drug Infusion
Drug solutions were infused i.c. (0.5 ml, 0.15 ml/min). In rotometry experiments,
the animals were injected with vehicle in the contralateral DLS. Drugs used
were as follows: apamin (0.08 ng dissolved in 0.9% saline), AM251 (0.5 ng
in 0.2% DMSO in saline), CAY10594 (22 ng in 0.2% DMSO in saline),
PD0325901 (5 pg in 0.2% DMSO in saline), or DPCPX (0.07 ng in 0.2%
DMSO in saline). Cannula placement for the various pharmacological experi-
ments is shown in Figure S8.
Motor Behavior
Locomotor activity and rotational behavior were assessed by using the ANY-
maze video tracking system (Stoelting). In rotarod experiments, behavioral
training and testing took place on a TSEmouseRotaRod system (TSESystems
GmbH).
Electrophysiology
Horizontal slices (270 mm) were prepared as described previously (Nazzaro
et al., 2012). Whole-cell current-clamp recordings in the DLS were conducted
in potassium-methylsulfate-based internal solution (130 mM KMeSO4, 5 mM
KCl, 5 mM NaCl, 10 mM HEPES, 2 mM MgCl2, 0.1 mM EGTA, 0.05 mM
CaCl2, 2 mM Na2ATP, and 0.4 mM Na3GTP [pH 7.2–7.3, 280–290 mOsm/kg]).
EPSPs were evoked by stimulation of the deep cortical layer 5 of the
somatosensory cortex in the presence of the GABAA receptor antagonist
gabazine (10 mM). During HFS-plasticity induction (4 3 1 s long 100-Hz
trains, repeated every 10 s), the postsynaptic cell was depolarized from
80 to 50 mV. Paired-pulse facilitation (PPF) was elicited by twin cortical
stimuli (100-ms interval).
Immunostaining
Mice were perfused with 4%paraformaldehyde (PFA, w/v) in phosphate buffer
(0.1 M PB [pH 7.4]), and cryostat sections (30 mm) were processed for immu-
nohistochemistry, immunofluorescence, or Nissl staining.
Measurement of Dopamine Depletion
Sections were blocked with Tris-buffered saline (0.3% Triton X-100 and
3% BSA) incubated in primary antibody against TH (1:700, Santa Cruz
Biotechnology), followed by secondary antibody and DAB-based revelation
(VECTASTAIN Elite ABC-Peroxidase Kit).
Assessment of ERK Pathway Activation
Coronal brain slices were incubated in rabbit polyclonal antibody against p-S6
(Ser235/236) or p44/42 MAPK (Erk1/2; Thr202/Tyr204; 1:200, Cell Signaling
Technology) and mouse anti-NeuN antibody (1:500, Millipore) in PBS contain-
ing 0.1 mM NaF, 0.3% TX, and 4% normal goat serum, followed by Alexa-
coupled secondary antibodies (1:1,000, Invitrogen). Images of the DLS (six
fields/mouse) were acquired, and the number of pERK- and pS6-positive
neurons was counted.
Identification of D2MSN and D1MSN
During electrophysiology experiments, MSNs were filled with Neurobiotin
(0.5 mg/ml) and slices were subsequently fixed with 4% PFA. Antigen retrieval
(sodium citrate 50mM, 30min, 80C) was performed, and the slices were incu-
bated in primary antibodies (anti-A2A, 1:250, Enzo Biosciences; and anti-
substance P, 1:200, Millipore, diluted in 0.1 M PB containing 0.3% [v/v] Triton
X-100 and 0.02% NaN3). Sections were then incubated in Alexa 568-conju-
gated streptavidin (1:5,000; Invitrogen) followed by secondary antibodies
(Invitrogen).1364 Cell Reports 13, 1353–1365, November 17, 2015 ª2015 The AuData Analysis
The occurrence and magnitude of synaptic plasticity was evaluated by
comparing the normalized EPSP amplitudes from the last 5 min of baseline re-
cordings with the corresponding values at 20–30 min after HFS (HFS-LTD) and
15–20 min and 30–35 from DHPG and ENBA application, respectively. LTD
plots were generated by averaging the peak amplitude of individual EPSPs
in 1-min bins. The CV for EPSP was calculated by the ratio of the SD and
the mean EPSP amplitude (Fino et al., 2005).
Statistics
Data were analyzed by one-way repeated-measures ANOVA (RM1W) for com-
parisons within a group and by one-way ANOVA (1W) and two-way (2W) or
two-way repeated-measures ANOVA (RM2W) for between-group compari-
sons (GraphPad Instat 3 software). Post hoc analyses (Tukey, Bonferroni,
and Holm-Sidak multiple comparison tests) were only performed for
ANOVAs that yielded significant main effects. For comparisons of two groups,
an independent two-sample t test was used (GraphPad Instat 3 software). Sta-
tistical figures for RM1W and 1W are reported in Table S1.
For detailed methods, see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
nine figures, and one table and can be found with this article online at http://
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